Cryptosporidiosis and Oral Tolerance
Cryptosporidiosis and Oral Tolerance
批准号:
10741600
负责人:
L. David Sibley
金额:
$23.35万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-06-23 至 2025-05-31
关键词:
AdultAgeAntigensArchitectureAutomobile DrivingCD4 Positive T LymphocytesCell physiologyCellsChildClinicalColonComplexCryptosporidiosisCryptosporidiumCryptosporidium parvumDefectDeveloping CountriesDevelopmentDietary FactorsDiseaseEnvironmentFOXP3 geneFailure to ThriveFoodGoblet CellsGrowthHeightHumanIL18 geneImmune responseImpairmentIndividualInfantInfectionInflammationIntestinesKnowledgeLifeLivestockMaintenanceMalnutritionMolecularMorbidity - disease rateMucosal Immune SystemMucosal ImmunityMucous MembraneMusNeonatalNewborn AnimalsOocystsOralOrganismOutcomePeripheralPlayPredispositionPrevalencePrimary InfectionProcessProductionRegulatory T-LymphocyteRoleSamplingShapesSignal TransductionTestingTimeVillusWeightZoonosesage relatedcommunity-level factordiarrheal diseasedietarydysbiosisenteric infectionfood antigenmesenteric lymph nodemicrobial communitymicrobiomemicrobiotamortalitymouse modelneonatal infectionneonatal miceoral tolerancepreventresponse
中文摘要
摘要
导致严重的死亡率和发病率。出现症状性疾病的儿童更有可能
患有营养不良和身高和体重较低的年龄,这些缺陷在
原发感染痊愈。令人惊讶的是,即使是没有症状的病例也可能与营养不良和
在最初感染后的几年里未能茁壮成长。这些发现表明,肠道的变化
在最初感染期间的功能建立了阻碍发育的持续性肠病。然而,
推动这一临床结果的细胞和分子机制仍未解决。在早期开发期间
产生外周T调节细胞(PTreg),抑制对饮食抗原的免疫反应,并
共生关系。这一早期形成粘膜免疫系统的过程对口腔的维持至关重要
在以后的生活中宽容。我们的研究检验了一个有趣的假设,即早期生活中的隐孢子虫病会改变
通过破坏口服耐受性对管腔抗原的反应,这种耐受性通常发生在这一时期。在……里面
我们的初步研究表明,新生小鼠对微小弧菌感染高度敏感,
显示与抗原采样相关的杯状细胞功能缺陷。此外,我们还证明了微小隐孢子虫
感染的新生小鼠减少了pTreg细胞的发育。我们将探讨这样的假设
隐孢子虫病通过两个主要目的破坏口服耐受性:1)确定
杯状细胞对抗原采样的干扰,2)探讨pTreg发育中断对
口服耐受性。这些研究将探索如何改变对饮食抗原或共生的免疫反应
肠道感染后,微生物会引发炎症,损害肠道功能。
英文摘要
ABSTRACT
Cryptosporidiosis is an important cause of diarrheal disease in young children in the developing world where it
causes significant mortality and morbidity. Children that present with symptomatic disease are more likely to
suffer from malnutrition and lower height and weight per age, and these deficiencies persist for years after the
primary infection resolves. Surprisingly even asymptomatic cases can be associated with malnutrition and
failure to thrive for several years beyond the initial infection. These findings suggest that alterations in intestinal
function during the initial infection establish persistent enteropathy that stunts development. However, the
cellular and molecular mechanisms driving this clinical outcome remain unresolved. During early development
of the intestine, Goblet cells play a critical role in sampling of antigens from the gut lumen in a process that
generates peripheral T regulatory cells (pTreg), which suppress immune responses to dietary antigens and
commensals. This early process in shaping the mucosal immune system is critical to maintenance of oral
tolerance later in life. Our study examines the intriguing hypothesis that cryptosporidiosis in early life alters
responses to lumenal antigens by disrupting oral tolerance that normally develops during this time period. In
preliminary studies we have shown that neonatal mice, which are highly susceptible to C. parvum infection,
show defects in Goblet cell functions related to antigenic sampling. Furthermore we show that C. parvum
infected neonatal mice have reduced development of pTreg cells. We will explore the hypothesis that
cryptosporidiosis disrupts oral tolerance through two main aims: 1) determine the molecular mechanism for
disruption of antigen sampling by Goblet cells, 2) explore the consequence of disrupted pTreg development on
oral tolerance. These studies will explore how altered immune responses to dietary antigens or commensal
organisms drive inflammation that impairs gut function following enteric infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of host cell egress by Toxoplasma gondii
-
批准号:10640220
-
项目类别:
-
资助金额:$61.44万
-
财政年份:2022
-
负责人:L. David Sibley
-
依托单位:
Regulation of host cell egress by Toxoplasma gondii
-
批准号:10441782
-
项目类别:
-
资助金额:$62.16万
-
财政年份:2022
-
负责人:L. David Sibley
-
依托单位:
Reactivation of Chronic Toxoplasmosis
-
批准号:10239417
-
项目类别:
-
资助金额:$24.82万
-
财政年份:2021
-
负责人:L. David Sibley
-
依托单位:
Interferon-mediated control mechanisms in human cells
-
批准号:10041166
-
项目类别:
-
资助金额:$23.63万
-
财政年份:2020
-
负责人:L. David Sibley
-
依托单位:
Interferon-mediated control mechanisms in human cells
-
批准号:10194376
-
项目类别:
-
资助金额:$19.69万
-
财政年份:2020
-
负责人:L. David Sibley
-
依托单位:
Effect of Microbial Metabolites on Growth of Cryptosporidium
-
批准号:9927337
-
项目类别:
-
资助金额:$68.39万
-
财政年份:2019
-
负责人:L. David Sibley
-
依托单位:
Effect of Microbial Metabolites on Growth of Cryptosporidium
-
批准号:10303025
-
项目类别:
-
资助金额:$67.07万
-
财政年份:2019
-
负责人:L. David Sibley
-
依托单位:
Effect of Microbial Metabolites on Growth of Cryptosporidium
-
批准号:10527363
-
项目类别:
-
资助金额:$67.07万
-
财政年份:2019
-
负责人:L. David Sibley
-
依托单位:
INHIBITION OF STAT TRANSCRIPTION BY TOXOPLASMA
-
批准号:9244190
-
项目类别:
-
资助金额:$22.88万
-
财政年份:2016
-
负责人:L. David Sibley
-
依托单位:
Molecular Basis of Human Toxoplasmosis
-
批准号:10557864
-
项目类别:
-
资助金额:$66.82万
-
财政年份:2015
-
负责人:L. David Sibley
-
依托单位:
Molecular Basis of Human Toxoplasmosis
-
批准号:10359216
-
项目类别:
-
资助金额:$66.82万
-
财政年份:2015
-
负责人:L. David Sibley
-
依托单位:
Molecular Basis of Human Toxoplasmosis
-
批准号:8920930
-
项目类别:
-
资助金额:$53.75万
-
财政年份:2015
-
负责人:L. David Sibley
-
依托单位:
Molecular Basis of Human Toxoplasmosis
-
批准号:10010540
-
项目类别:
-
资助金额:$66.73万
-
财政年份:2015
-
负责人:L. David Sibley
-
依托单位:
DESIGNING SELECTIVE INHIBITORS OF CALCIUM-DEPENDENT KINASES IN PARASITES
-
批准号:8680125
-
项目类别:
-
资助金额:$36.8万
-
财政年份:2012
-
负责人:L. David Sibley
-
依托单位:
DESIGNING SELECTIVE INHIBITORS OF CALCIUM-DEPENDENT KINASES IN PARASITES
-
批准号:8258101
-
项目类别:
-
资助金额:$50.49万
-
财政年份:2012
-
负责人:L. David Sibley
-
依托单位:
DESIGNING SELECTIVE INHIBITORS OF CALCIUM-DEPENDENT KINASES IN PARASITES
-
批准号:8495237
-
项目类别:
-
资助金额:$44.89万
-
财政年份:2012
-
负责人:L. David Sibley
-
依托单位:
DESIGNING SELECTIVE INHIBITORS OF CALCIUM-DEPENDENT KINASES IN PARASITES
-
批准号:8856479
-
项目类别:
-
资助金额:$29.49万
-
财政年份:2012
-
负责人:L. David Sibley
-
依托单位:
TARGETING ESSENTIAL ROP KINASES IN TOXOPLASMA
-
批准号:8205613
-
项目类别:
-
资助金额:$43.02万
-
财政年份:2011
-
负责人:L. David Sibley
-
依托单位:
TARGETING ESSENTIAL ROP KINASES IN TOXOPLASMA
-
批准号:8291991
-
项目类别:
-
资助金额:$43.0万
-
财政年份:2011
-
负责人:L. David Sibley
-
依托单位:
TARGETING ESSENTIAL ROP KINASES IN TOXOPLASMA
-
批准号:8513125
-
项目类别:
-
资助金额:$40.42万
-
财政年份:2011
-
负责人:L. David Sibley
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: